Ezicipro 0.3% Eye Drop is an antibiotic, used in the treatment of bacterial infections of the eye. It relieves the symptoms of the infection by stopping the further growth of the causative microorganisms.

Ezicipro 0.3% Eye Drop is used to treat variety of infections caused by multiple organisms which affect various parts of the body

Uses of Ezicipro Eye Drop

Bacterial eye infections

Benefits of Ezicipro Eye Drop

In Bacterial eye infections

Ezicipro 0.3% Eye Drop is an antibiotic medicine. It works by stopping the growth of the bacteria that is causing the infection. It helps relieve symptoms such as pain, redness, itching or soreness caused due to eye infections. The dose and duration of treatment will be decided by your doctor based on your condition. Make sure you complete the full course of treatment. This will ensure that the infection is completely cured and prevent it from returning.

Side effects of Ezicipro Eye Drop

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Common side effects of Ezicipro

Corneal deposits
Eye discomfort
Ocular hyperemia
Taste change

How to use Ezicipro Eye Drop

This medicine is for external use only. Use it in the dose and duration as advised by your doctor. Check the label for directions before use. Hold the dropper close to the eye without touching it. Gently squeeze the dropper and place the medicine inside the lower eyelid. Wipe off the extra liquid.

How Ezicipro Eye Drop works

Ezicipro 0.3% Eye Drop is an antibiotic. It treats bacterial eye infections by preventing the bacteria from dividing and repairing. It does so stopping the action of a bacterial enzyme called DNA-gyrase.

Safety advice

Alcohol

No interaction found/established

Pregnancy

CONSULT YOUR DOCTOR

Ezicipro 0.3% Eye Drop may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

Breast feeding

SAFE IF PRESCRIBED

Ezicipro 0.3% Eye Drop is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Baby should be closely monitored for development of fever, loss of appetite and diarrhea. In case, any of the above happens please inform your doctor immediately.

Driving

UNSAFE

Ezicipro 0.3% Eye Drop may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.

Kidney

No interaction found/established

Liver

No interaction found/established

All substitutes

For informational purposes only. Consult a doctor before taking any medicines.

Ezicipro 0.3% Eye Drop

₹12.0/Eye Drop

Ciprozen Eye Drop

Klar Sehen Pvt Ltd

₹15.46/eye drop

29% costlier

Nircip Eye Drop

Nirlife Healthcare

₹6/eye drop

50% cheaper

Cipad Eye Drop

Albert David Ltd

₹7.82/eye drop

35% cheaper

Ciprozen Eye Drop

Klar Sehen Pvt Ltd

₹10.12/eye drop

16% cheaper

Joxin Eye Drop

Jawa Pharmaceuticals Pvt Ltd

₹7.28/eye drop

39% cheaper

View all substitutes

Quick tips

Do not skip any doses and finish the full course of treatment with Ezicipro 0.3% Eye Drop even if you feel better.
Apply pressure on the corner of the eye (close to the nose) for about 1 minute, immediately after instilling the medication.
Do not touch the tip to any surface, or to your eye, to avoid contamination.
Wait for at least 5-10 minutes before delivering the next medication in the same eye to avoid dilution.
Ezicipro 0.3% Eye Drop may cause short term blurring of vision when first used. Use caution before driving or using machines.
Do not wear contact lenses until your infection clears up.
Make sure to Ezicipro 0.3% Eye Drop use within 4 weeks of opening the medication.

Fact Box

Chemical Class

Fluoroquinolone

Habit Forming

Therapeutic Class

OPHTHAL

Action Class

Quinolones/ Fluroquinolones

Patient concerns

Scar on face due to bacterial infections

Dr. Atul Jain

Dermatology

Pic is not clear, plz visit for proper opinion

I have a history of recurring yeast and bacterial vaginosis infections.

Dr. Sonu Balhara Ahlawat

Obstetrics and Gynaecology

Tab metrogyl 500 mg twice a day x 5 days and tab fluconazole 150 mg three doses alternate days

Want to share the information?

Disclaimer:

Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.

References

Petri WA Jr. Sulfonamides, Trimethoprim-Sulfamethoxazole, Quinolones, and Agents for Urinary Tract Infections. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 1473-74.
Chambers HF, Deck DH. Sulfonamides, Trimethoprim, & Quinolons. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. pp. 819-20.
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 275-78.
Ciprofloxacin. Camberley Surrey: Novartis Pharmaceuticals UK Limited; 1993 [revised 01 May 2017]. [Accessed 01 Apr.2019] (online) Available from:
Chaves RG, Lamounier JA. Breastfeeding and maternal medications. J Pediatr (Rio J). 2004;80(5 Suppl):S189-98. [Accessed 01 Apr. 2019] (online) Available from:
Central Drugs Standard Control Organisation (CDSCO). [Accessed 01 Apr. 2019] (online) Available from:

Marketer details

Name: DR Best pharmaceuticals Pvt Ltd

Address: Plot No.-157-A (G-2) Periphery Road, Sarangpur, Chandigarh (U.T.)

Country of origin: India

The list of available options shown with the same composition has been prepared upon the advice of registered medical practitioners, pharmacists affiliated with TATA 1MG. TATA 1MG does not promote any pharmaceutical product of any particular company, and all recommendations are based on the medical opinion, advisories from specialist medical and pharmaceutical professionals.